FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Perrigo Co's Free Cash Flow for the
three
months ended in Mar. 2026 was MXN-2,297 Mil. Perrigo Co's Revenue for the
three
months ended in Mar. 2026 was MXN17,477 Mil. Therefore, Perrigo Co's FCF Margin % for the quarter that ended in Mar. 2026 was -13.14%.
The historical rank and industry rank for Perrigo Co's FCF Margin % or its related term are showing as below:
MEX:PRGON'
s FCF Margin % Range Over the Past 10 Years
Min: 0.1 Med: 6.5 Max: 12.34
Current: 2.68
During the past 13 years, the highest FCF Margin % of Perrigo Co was 12.34%. The lowest was 0.10%. And the median was 6.50%.
MEX:PRGON's FCF Margin % is ranked better than 50.21% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs MEX:PRGON: 2.68
Perrigo Co FCF Margin % Related Terms
Perrigo Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Perrigo Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PRGON vs AMLX, HROW, ANIP: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Perrigo Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (MEX:PRGON) has a FCF Margin % of -13.14% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Perrigo Co and its competitors. Over the past decade, Perrigo Co's FCF Margin % has ranged from 0.10 to 12.34. According to the industry distribution chart, Perrigo Co ranks #477 out of 958 companies in the Drug Manufacturers industry, placing it in the top 49.8%.
Is Perrigo Co's FCF Margin % too high?
Perrigo Co's current FCF Margin % is -13.14%. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 12.34. Based on the distribution chart, Perrigo Co ranks #477 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Perrigo Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's FCF Margin % compare to AMLX and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #477 out of 958 companies for FCF Margin %. This puts Perrigo Co in the upper half of its industry. The industry median FCF Margin % is 2.51. Historically, Perrigo Co's own FCF Margin % has ranged from 0.10 to 12.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current FCF Margin % is -13.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current FCF Margin % of -13.14%. The stock's GF Value™ is MXN1,468.70, compared to a current price of MXN557.52 — trading 62% below its estimated fair value. The current FCF Margin % is -13.14%. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current FCF Margin % is -13.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (MEX:PRGON) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of MXN557.52 is trading 62% below its estimated GF Value™ of MXN1,468.70.
Key valuation signals for MEX:PRGON:
FCF Margin %: -13.14%
GF Value™: MXN1,468.70 vs. price of MXN557.52 (62% below fair value)
No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score
Get the complete analysis for MEX:PRGON
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PRGON has been successfully added to your 
